Guardant Health, Inc. (GH)
NASDAQ: GH · Real-Time Price · USD
159.79
+1.39 (0.88%)
Jul 14, 2026, 2:46 PM EDT - Market open
Guardant Health Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -433.19 | -416.28 | -436.37 | -479.45 | -654.59 | -384.77 |
Depreciation & Amortization | 38.94 | 39.74 | 42.39 | 42.88 | 35.96 | 22.27 |
Stock-Based Compensation | 176.07 | 166.22 | 140.41 | 90.76 | 94.69 | 151.45 |
Other Adjustments | 57.71 | 39.99 | 74.58 | -33.01 | 152.91 | 42.5 |
Change in Receivables | -21.12 | -28.18 | -21.39 | 8.38 | 0.38 | -44.35 |
Changes in Inventories | -6.59 | -14.79 | -9.14 | -10.35 | -20.93 | -7.96 |
Changes in Accounts Payable | 46.06 | 52.75 | -2.82 | 5.19 | 60.33 | 34.8 |
Changes in Accrued Expenses | - | - | - | 83.4 | - | - |
Changes in Unearned Revenue | 13.8 | 19.46 | 18.66 | 1.73 | 9.87 | 2.78 |
Changes in Other Operating Activities | -46.51 | -43.67 | -46.18 | -34.51 | 11.91 | -25.73 |
Operating Cash Flow | -187.69 | -184.76 | -239.86 | -324.98 | -309.46 | -209.02 |
Capital Expenditures | -49.43 | -48.31 | -35.09 | -20.49 | -77.46 | -75.04 |
Purchases of Investments | -6.5 | -827.23 | -314.82 | -635.5 | -327.72 | -940.23 |
Proceeds from Sale of Investments | 954.93 | 307.32 | 88.6 | 1,496 | 555 | 952.11 |
Payments for Business Acquisitions | - | -58.99 | - | - | - | - |
Investing Cash Flow | -230.65 | -627.2 | -261.31 | 840.25 | 149.82 | -63.16 |
Long-Term Debt Issued | - | 402.5 | - | - | - | - |
Net Long-Term Debt Issued (Repaid) | - | 402.5 | - | - | - | - |
Issuance of Common Stock | 31.85 | 360.14 | 14.84 | 482.54 | 11.94 | 17.87 |
Repurchase of Common Stock | -35.69 | -75.55 | -15.68 | -11.2 | -7.88 | -83.76 |
Net Common Stock Issued (Repurchased) | -3.84 | 284.6 | -0.84 | 471.35 | 4.06 | -65.89 |
Other Financing Activities | -13.43 | -15.96 | -0.15 | 6.03 | -193.16 | -0.93 |
Financing Cash Flow | 716.41 | 671.13 | -1 | 477.38 | -189.09 | -66.82 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | -0.48 | 0.49 | -1.77 | -0.91 | -1.6 | -1.69 |
Net Cash Flow | 6.9 | -140.34 | -503.93 | 991.74 | -350.34 | -340.69 |
Free Cash Flow | -237.12 | -233.07 | -274.94 | -345.46 | -386.92 | -284.05 |
FCF Margin | -21.95% | -23.73% | -37.20% | -61.26% | -86.07% | -76.02% |
Free Cash Flow Per Share | -1.86 | -1.86 | -2.24 | -3.08 | -3.79 | -2.80 |
Levered Free Cash Flow | -436.92 | -8.6 | -468.54 | -411.59 | -634.9 | -454.55 |
Unlevered Free Cash Flow | -450.07 | -430.75 | -477.07 | -498.03 | -525.64 | -460.2 |